Latest Articles
Hypothesis Open Access

Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti- Reward
Kenneth Blum, Marlene Oscar-Berman, Eric R. Braverman, Marcelo Febo, Mona Li and Mark S. Gold
Published on: February 27, 2015
doi: 10.17756/jrds.2015-005
Citation: Blum K, Oscar-Berman M, Braverman ER, Febo M, Li M, et al. 2015. Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward. J Reward Defic Syndr 1(1): 20-23.
HTML (View Full text) | PDF (Download Full text) | PMC Full text
Rebuttal Commentary Open Access

Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely?
Rajendra D. Badgaiyan, Sampada Sinha and Kenneth Blum
Published on: February 25, 2015
doi: 10.17756/jrds.2015-004
Citation: Badgaiyan RD, Sinha S, Blum K. 2015. Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely? J Reward Defic Syndr 1(1): 16-19.
HTML (View Full text) | PDF (Download Full text)
Commentary Open Access

Individualizing Opioid Use Disorder (OUD) Treatment: Time to Fully Embrace a Chronic Disease Model
Richard Gustin, Jake Nichols and Peter R. Martin
Published on: February 19, 2015
doi: 10.17756/jrds.2015-003
Citation: Gustin R, Nichols J, Martin PR. 2015. Individualizing Opioid Use Disorder (OUD) Treatment: Time to Fully Embrace a Chronic Disease Model. J Reward Defic Syndr 1(1): 10-15.
HTML (View Full text) | PDF (Download Full text)
Short Commentary Open Access

Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future Research
Edward Justin Modestino, Kenneth Blum, Marlene Oscar-Berman, Mark S. Gold, Drake D. Duane, Sarah G.S. Sultan, and Sanford H. Auerbach
Published on: February 6, 2015
doi: 10.17756/jrds.2015-002
Citation: Modestino EJ, Blum K, Oscar-Berman M, Gold MS, Duane DD, et al. 2015. Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future Research. J Reward Defic Syndr 1(1): 6-9.
HTML (View Full text) | PDF (Download Full text) | PMC Full text
Letter to the Editor Open Access

Should We Embrace Vaccines for Treating Substance- Related Disorder, A Subset of Reward Deficiency Syndrome (RDS)?
Kenneth Blum, Rajendra D. Badgaiyan, Daniel H. Angres and Mark S. Gold
Published on: January 29, 2015
doi: 10.17756/jrds.2015-001
Citation: Blum K, Badgaiyan RD, Angres DH, Gold MS. 2015. Should We Embrace Vaccines for Treating Substance-Related Disorder, A Subset of Reward Deficiency Syndrome (RDS)? J Reward Defic Syndr 1(1): 3-5.
HTML (View Full text) | PDF (Download Full text)
Editorial Open Access

Reward Deficiency Syndrome (RDS): Entering the Genomics and Neuroscience Era of Addiction Medicine
Kenneth Blum and Rajendra D. Badgaiyan
Published on: January 15, 2015
doi: 10.17756/jrds.2015-e001
Citation: Blum K, Badgaiyan RD (2015) Reward Deficiency Syndrome (RDS): Entering the Genomic & Neuroscience of Addiction Era. J Reward Defic Syndr 1(1): 1-2.
HTML (View Full text) | PDF (Download Full text)